Conversion Improves Capital Structure, and Reinforces Nasdaq Compliance, Enhancing Shareholder Value Company Believes That Substantially All of the Converted Shares Have Been Sold FREEHOLD, N.J., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a diversified company focused on the development of precision diagnostic consumer products and generative AI publishing and software, today announced the conversion of the majority of its outstanding debentures, sig ...

The most oversold stocks in the real estate sector presents an opportunity to buy into undervalued companies.The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days when prices go down. When compared to a stock’s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the RSI is below 30, according to Benzinga Pro.Here's the latest list of major oversold players ...

The most oversold stocks in the real estate sector presents an opportunity to buy into undervalued companies.The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days when prices go down. When compared to a stock’s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the RSI is below 30, according to Benzinga Pro.Here's the latest list of major oversold players ...

Provisional Patent Application Covers Systems and Methods for Evidence-Constrained, Audience-Adaptive Generation of Automated Commentary VideosFREEHOLD, N.J., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a diversified company focused on the development of precision diagnostic consumer products and generative AI publishing and software, today announced that its subsidiary, Avalon Quantum AI LLC, has filed a U.S. provisional patent application covering a ...

Avalon GloboCare Corp (NASDAQ:ALBT) stock is trading lower on Wednesday. Apparently, there is no news to justify the movement.Avalon GloboCare, a company for precision diagnostic consumer products, on Tuesday announced the renewal of the U.S. Food and Drug Administration (FDA) establishment registration for its KetoAir device, a handheld breathalyzer designed for ketogenic health management.The device measures breath acetone concentration (BrAce), a key biomarker associated with fat metabolism and nutrition ...

Core Insights - Avalon GloboCare Corp. has renewed the U.S. FDA establishment registration for the KetoAir™ device, a handheld breathalyzer for ketogenic health management [1][5] - The KetoAir™ device measures breath acetone concentration, providing real-time insights into metabolic state for individuals on ketogenic diets [2][5] - Avalon plans to launch KetoAir™ in both B2B and B2C markets using its Catch-Up™ platform, which is powered by generative AI for marketing and distribution [3][4] Company Overview - Avalon GloboCare Corp. is focused on developing precision diagnostic consumer products and advancing intellectual property in cellular therapy and generative AI [5] - The KetoAir™ device is registered as a Class I medical device with the FDA and is intended for weight management, athletic performance, and lifestyle-based ketogenic programs [2][5] - The company is also advancing its intellectual property portfolio through existing patent applications and operates commercial real estate [5]

Core Viewpoint - Avalon GloboCare Corp. has regained compliance with Nasdaq's minimum stockholders' equity requirement, allowing its common stock to continue being listed and traded on the Nasdaq Capital Market [1][2][3] Company Overview - Avalon GloboCare Corp. is a diversified company focused on developing precision diagnostic consumer products and advancing intellectual property in cellular therapy and generative AI publishing and software [4] - The company is currently marketing the KetoAir™ breathalyzer device, which is registered with the U.S. FDA as a Class I medical device, and plans to develop additional diagnostic uses for this technology [4] Financial Position - The company has made progress in strengthening its financial position, which is reflected in its regained compliance with Nasdaq's requirements [3] - The cancellation of the previously scheduled hearing before the Nasdaq Hearings Panel indicates a positive development for the company's stock listing status [2] Growth Initiatives - With full Nasdaq compliance restored, the company is positioned to execute growth initiatives, including launching marketing for its generative AI video platform and expanding its precision diagnostics and strategic assets [3]

Core Viewpoint - Avalon GloboCare Corp. has regained compliance with Nasdaq's minimum stockholders' equity requirement, allowing its common stock to continue being listed and traded on the Nasdaq Capital Market [1][2]. Financial Compliance - Nasdaq confirmed that Avalon is now in compliance with all applicable continued listing standards, leading to the cancellation of a previously scheduled hearing before the Nasdaq Hearings Panel [2]. - The company expressed satisfaction with its regained compliance, highlighting the progress made in strengthening its financial position and focusing on long-term shareholder value [3]. Growth Initiatives - With full Nasdaq compliance restored, Avalon is positioned to execute growth initiatives, including launching marketing for its generative AI video platform and expanding in precision diagnostics and strategic assets [3]. Company Overview - Avalon GloboCare Corp. is focused on developing precision diagnostic consumer products and advancing intellectual property in cellular therapy and generative AI publishing and software through its subsidiary Avalon Quantum AI, LLC [4]. - The company is currently marketing the KetoAir™ breathalyzer device, which is registered with the U.S. Food and Drug Administration as a Class I medical device, and plans to develop additional diagnostic uses for this technology [4].

Core Viewpoint - Avalon GloboCare Corp. has acquired RPM Interactive, Inc., a generative AI publishing and software company, and is focusing on the development and commercialization of the Catch-Up platform, a SaaS solution for automated video generation [1][2]. Group 1: Acquisition and Leadership - Michael Mathews, CEO of RPM and a board member of Avalon, discussed the acquisition and its implications during an interview [1]. - The acquisition of RPM is part of Avalon's strategy to enhance its product offerings in the precision diagnostic consumer products sector [1]. Group 2: Catch-Up Platform Development - The Catch-Up platform is designed to automatically generate recap-style videos using generative AI applications and large language models [2]. - This platform will be marketed to content creators, media companies, and brands, allowing them to produce videos without manual editing or technical expertise [3]. Group 3: Marketing and Product Integration - Avalon plans to utilize the Catch-Up platform to support marketing initiatives for its KetoAir™ breathalyzer, which is FDA-registered and aimed at helping consumers manage their wellness [4]. - The integration of the Catch-Up platform is expected to enhance the volume of video content produced by content creators, thereby increasing engagement and visibility [3].

Core Viewpoint - Avalon GloboCare Corp. has acquired RPM Interactive, Inc., a generative AI publishing and software company, and is focusing on the development and commercialization of the Catch-Up platform, a SaaS solution for automated video generation [1][2]. Group 1: Acquisition and Leadership - Michael Mathews, CEO of RPM and a board member of Avalon, discussed the acquisition and its implications during an interview [1]. - The acquisition of RPM is expected to enhance Avalon's capabilities in precision diagnostics and consumer products [1]. Group 2: Catch-Up Platform Development - The Catch-Up platform is designed to automatically generate recap-style videos using generative AI applications and large language models [2]. - This platform will be marketed to content creators, media companies, and brands, allowing them to produce videos without manual editing or technical expertise [3]. Group 3: Marketing and Product Integration - Avalon plans to utilize the Catch-Up platform to support marketing initiatives for its KetoAir™ breathalyzer, which is FDA-registered and aimed at helping consumers manage their wellness [4]. - The integration of the Catch-Up platform is expected to increase the volume of video content produced by users, thereby enhancing marketing efforts for Avalon’s products [3][4].